NasdaqCM - Delayed Quote • USD
ARCA biopharma, Inc. (ABIO)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:25 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
7,296.0000
7,296.0000
10,596.0000
19,335.0000
9,766.0000
Operating Income
-7,296.0000
-7,296.0000
-10,596.0000
-19,335.0000
-9,766.0000
Net Non Operating Interest Income Expense
1,957.0000
1,957.0000
675.0000
13.0000
19.0000
Other Income Expense
--
--
-5.0000
--
--
Pretax Income
-5,339.0000
-5,339.0000
-9,926.0000
-19,322.0000
-9,747.0000
Tax Provision
--
--
--
--
-9.0000
Net Income Common Stockholders
-5,339.0000
-5,339.0000
-9,926.0000
-19,322.0000
-9,738.0000
Diluted NI Available to Com Stockholders
-5,339.0000
-5,339.0000
-9,926.0000
-19,322.0000
-9,738.0000
Basic EPS
-0.37
-0.37
-0.69
-1.39
-2.07
Diluted EPS
-0.37
-0.37
-0.69
-1.39
-2.07
Basic Average Shares
14,415.8770
14,415.8770
14,410.1430
13,903.8710
4,710.2370
Diluted Average Shares
14,415.8770
14,415.8770
14,410.1430
13,903.8710
4,710.2370
Total Operating Income as Reported
-7,296.0000
-7,296.0000
-10,596.0000
-19,335.0000
-9,766.0000
Total Expenses
7,296.0000
7,296.0000
10,596.0000
19,335.0000
9,766.0000
Net Income from Continuing & Discontinued Operation
-5,339.0000
-5,339.0000
-9,926.0000
-19,322.0000
-9,738.0000
Normalized Income
-5,339.0000
-5,339.0000
-9,926.0000
-19,322.0000
-9,738.0000
Interest Income
1,957.0000
1,957.0000
675.0000
13.0000
28.0000
Interest Expense
--
--
--
--
9.0000
Net Interest Income
1,957.0000
1,957.0000
675.0000
13.0000
19.0000
EBIT
-7,296.0000
-7,296.0000
-10,596.0000
-19,335.0000
-9,738.0000
EBITDA
-7,185.0000
-7,185.0000
-10,482.0000
-19,244.0000
-9,645.0000
Reconciled Depreciation
111.0000
111.0000
114.0000
91.0000
93.0000
Net Income from Continuing Operation Net Minority Interest
-5,339.0000
-5,339.0000
-9,926.0000
-19,322.0000
-9,738.0000
Normalized EBITDA
-7,185.0000
-7,185.0000
-10,482.0000
-19,244.0000
-9,645.0000
Tax Rate for Calcs
--
--
--
--
0.0000
12/31/2020 - 8/8/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHIO Phio Pharmaceuticals Corp.
0.6820
+1.34%
JAGX Jaguar Health, Inc.
0.1800
+5.88%
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%
CYCC Cyclacel Pharmaceuticals, Inc.
1.5100
-5.63%
NKGN NKGen Biotech, Inc.
1.6100
-18.69%
ACRV Acrivon Therapeutics, Inc.
8.46
-0.12%
LGVN Longeveron Inc.
1.7500
+4.79%
ADIL Adial Pharmaceuticals, Inc.
1.6100
-6.94%
IBIO iBio, Inc.
1.7600
+2.33%
CLNN Clene Inc.
0.3399
-1.90%